The Editorial Board of the RGNUL Financial and Mercantile Law Review (RFMLR) invites blog posts from legal practitioners, academicians, research fellows, undergraduate students, postgraduate students etc. for the RFMLR Sidebar.

About the Review 

RGNUL Financial and Mercantile Law Review was set up as an academic initiative to promote research and debate in areas of financial and economic law. The review looks to understand the legal paradigm prevalent in India and South East Asia and how it affects finance and other cross border mercantile activities. The journal aims at giving an opportunity to legal academia, research scholars, legal practitioners and students to publish work that is at the cutting edge of doctrinal, theoretical, and empirical research.

About our new “Sectoral Series” 

RFMLR is initiating discourse on various sectors of the Indian economy through the medium of blogs. Our aim is to analyze different sectors of the economy vis-à-vis recent and projected policy changes. The series shifts its focus every three weeks. After an overwhelming response for the first theme, the Ailing Aviation Sector, RFMLR Sidebar is back with another sector of the Indian Economy.

The next theme in the instant series is, “Progressing Pharmaceutical Sector: A Legal and Economic Analysis”, and some of the suggested (not exhaustive) sub-themes are:

1. The Biosimilar Segment: Recommended Policy Boosts

   2. Rationalizing taxes in the Healthcare Sector: A need of the hour?

   3. Digital Healthcare: An upcoming investment avenue

   4. Ayushman Bharat: Implications for the Pharmaceutical Sector

   5. The Case for De-regulation: A bitter pill to swallow

   6. Private Partnerships in Secondary and Tertiary Healthcare Sectors
One best blog from each sector shall be featured under “Best Blogs of the Series”, as adjudicated by the Editorial Board.

Submission Guidelines:

1) The co-authorship is limited to a maximum of two authors.

 2) All submissions must be in Times New Roman, font size 12 and Spacing 1.5

3) Submission should contain endnotes instead of footnotes. All endnotes shall be in Times New Roman, font size 10 and single-spaced.

4) Word Limit for each submission is between 1000 to 1300 words (exclusive of Endnotes).

 5) The submission should be accompanied with a covering letter specifying the author’s name, designation, institute, contact number and e-mail for future reference.

6) All entries should be submitted in .doc or .docx format.

 7) All selected entries will be published on the RFMLR Sidebar at

 8) A certificate of appreciation will be given to authors who have a minimum of 3 entries published on the sidebar.

 9) The entries must be original, unpublished and an outcome of the author’s own efforts. The plagiarism limit is 12%. 

10) Please note that this series has sectors of the Indian Economy at its focus. All entries must compulsorily include a sub-heading dealing with the implications for the Pharmaceutical Industry as a sector of the Indian Economy, in light of the foregoing discussion on the theme chosen by the author(s).

11) The authors by submitting their entry would be deemed to have divested the copyright to RFMLR. However, all moral rights shall remain with the author(s).

Citation Format 
The Bluebook, A Uniform System of Citation (20th Ed.) is to be followed for citation. All footnotes must be in Times New Roman, font size 10, single-spacing and justified text.
Submission Deadline:
All submissions must be e-mailed to with the subject “Blog Submission for RFMLR Sidebar- Pharmaceutical Sector” latest by 25th July, 2019.

Contact Details 

For any queries, please feel free to contact the Editorial Board at

Join the discussion

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.